Ipamorelin’s Protective Effects on Periodontal Disease in American Males: A Four-Year Study
Reading Time: 2 minutes Introduction Ipamorelin, a selective growth hormone secretagogue, has garnered attention for its potential in enhancing muscle growth and improving overall health. However, its effects on dental health and periodontal disease remain underexplored. This article delves into a four-year dental study conducted on American males to elucidate the relationship between Ipamorelin use and oral health outcomes, specifically focusing on periodontal disease. Study Design and Methodology The study involved 200 American males aged 30 to 60, who were randomly assigned to either an Ipamorelin treatment group or a placebo group. Participants in the treatment group received a daily dose of Ipamorelin, while...


